TheraRNA

Nanjing, China · Founded 2019 · Privately Held (backing)

Manufacturer of mRNA vaccine drugs designed to treat infectious diseases and cancers. TheraRNA is based in Nanjing, China and was founded in 2019. Its last reported valuation was $27.9 million in Dec 2022. It has raised $6.4 million.

Last reported valuation
$27.9M
Oct 2026
Priced at
—
Total raised
$6.4M
Last round
—

Who backs TheraRNA?

4 investors
InvestorType
Oriental Fortune CapitalVenture capital
Shenzhen Weltrust Investment Co.Hedge fund
CrowdBees—
Share Capital—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

TheraRNA investors

4 investors are on record for TheraRNA, including Oriental Fortune Capital, Shenzhen Weltrust Investment Co., CrowdBees and Share Capital.

Free account
More of TheraRNA with a free account
  • ·Watch TheraRNA: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 4 firms already write checks for companies like TheraRNA. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View